Details for New Drug Application (NDA): 204768
✉ Email this page to a colleague
NDA 204768 describes TIVORBEX, which is a drug marketed by Genus and is included in one NDA. There are three patents protecting this drug. Additional details are available on the TIVORBEX profile page.
The generic ingredient in TIVORBEX is indomethacin. There are fifteen drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the indomethacin profile page.
The generic ingredient in TIVORBEX is indomethacin. There are fifteen drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the indomethacin profile page.
Summary for 204768
| Tradename: | TIVORBEX |
| Applicant: | Genus |
| Ingredient: | indomethacin |
| Patents: | 3 |
Medical Subject Heading (MeSH) Categories for 204768
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 20MG | ||||
| Approval Date: | Feb 24, 2014 | TE: | RLD: | Yes | |||||
| Patent: | 8,734,847 | Patent Expiration: | Apr 23, 2030 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
| Patent: | 8,992,982 | Patent Expiration: | Apr 23, 2030 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
| Patent: | 9,089,471 | Patent Expiration: | Apr 23, 2030 | Product Flag? | Substance Flag? | Delist Request? | |||
| Patented Use: | TREATMENT OF PAIN | ||||||||
Complete Access Available with Subscription
